Hobbs F D, Cherry R C, Fielding J W, Pike L, Holder R
University of Birmingham.
BMJ. 1992 Feb 22;304(6825):483-6. doi: 10.1136/bmj.304.6825.483.
To test patient compliance for faecal occult blood testing in suburban and inner city general practice.
Prospective opportunistic trial using the Haemoccult test kit. Tests were offered during routine surgery attendance.
Three group general practices in Birmingham.
All patients aged 40 years or older on the start date who routinely attended surgery during two years.
Numbers of patients approached for testing and the numbers refusing, accepting, and returning the test kits.
Only 26.3% (1230/4677) of the potential target population had been screened within the two years, although 988 (39.3%) of the suburban practice target were screened. However, 55.7% (1230/2207) of patients actually offered a test returned completed kits, with only 6% (133) refusing the kit. 683 (61.6%) patients aged 50-69 returned kits, compared with 343 (54.3%) aged 70 or over and 204 (43.8%) aged 40-49. These differences were significant (p less than 0.001). Patients from the inner city practice were significantly less likely to be offered the test than those in suburban practice (242 (11.2%) v 988 (39.9%), p less than 0.001) and return the samples (242 (38.8%) v 988 (62.4%), p less than 0.001). Patients from the inner city practice were also more likely to refuse the test (78 (12.5%) v 55 (3.5%), p less than 0.001).
Opportunistic testing for occult faecal blood in asymptomatic patients was reasonably acceptable to patients, especially those in a suburban practice. If the test is shown to reduce mortality from colorectal cancer then formal screening would probably achieve acceptable target rates, especially among patients aged 50-69, who represent the prime risk group.
检测郊区及市中心全科医疗中患者进行粪便潜血检测的依从性。
使用隐血检测试剂盒进行前瞻性机会性试验。在常规门诊就诊期间提供检测。
伯明翰的三组全科医疗机构。
起始日期时年龄在40岁及以上、在两年内定期到门诊就诊的所有患者。
接受检测的患者数量以及拒绝、接受和归还检测试剂盒的患者数量。
在两年内,仅26.3%(1230/4677)的潜在目标人群接受了筛查,尽管郊区医疗机构目标人群中有988人(39.3%)接受了筛查。然而,实际接受检测的患者中有55.7%(1230/2207)归还了已完成检测的试剂盒,只有6%(133人)拒绝了试剂盒。50 - 69岁的患者中有683人(61.6%)归还了试剂盒,70岁及以上的患者中有343人(54.3%),40 - 49岁年龄段的患者中有204人(43.8%)。这些差异具有统计学意义(p < 0.001)。市中心医疗机构的患者接受检测的可能性显著低于郊区医疗机构的患者(242人(11.2%)对988人(39.9%),p < 0.001),归还样本的可能性也较低(242人(38.8%)对988人(62.4%),p < 0.001)。市中心医疗机构的患者也更有可能拒绝检测(78人(12.5%)对55人(3.5%),p < 0.001)。
对无症状患者进行机会性潜血检测在患者中是比较容易接受的,尤其是郊区医疗机构的患者。如果该检测被证明能降低结直肠癌死亡率,那么正式筛查可能会达到可接受的目标率,尤其是在50 - 69岁的患者中,这一年龄段是主要风险人群。